EC Healthcare expects a record-high semi-annual sales volume in first half of FY23 of no less than HK$1.8 billion, Represents no less than 17% Y-o-Y increase
Demonstrate a Notable Recovery Trend and Moving Towards New Normal
HONG KONG, Oct 17, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group expects to achieve a record-high semi-annual sales volume from April to September 2022 (the "Reporting Period").
The demand on medical services provided by the Group remains strong and the Group's business demonstrate resilience and momentum backed by the Group's diversified business. The Board expects the Group to achieve a record-high semi-annual overall sales volume of no less than HK$1.8 billion for the Reporting Period, representing a no less than 17% y-o-y increase. The Group expects to achieve a no less than 30% y-o-y increase for medical services sales volume. Sales volume of other services rose by no less than 95% y-o-y, mainly driven by the acquisition of veterinary businesses.
Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, EC Healthcare is always committed to building a diversified healthcare ecosystem to maximize customers' lifetime value. Hong Kong resident now progressively building a herd immunity barrier with a population the cumulative number of reported cases of 5th wave of COVID-19 has reached over 181 million, population completed the third vaccine dose was at approximately 80.2% as of 13 October 2022. The steady recovery in local consumer sentiment is expected to benefit the Group's business. Looking ahead, the Group is optimistic about its business development as the Hong Kong government's pandemic policy stance is heading towards "Normalization" and recently further relaxed quarantine arrangements for inbound travelers, further boosting the market sentiment. The Group will continue to expand its businesses through organic growth as well as mergers and acquisitions, leveraging investment in IT, brand and service to enrich the Group's enclosed diversified ecosystem. The Group will further enhance the resilience and ability to resist economic cyclical changes and further consolidate the healthcare market."
About EC Healthcare EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.
The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.
*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021
For further information, please contact: iPR Ogilvy Limited Callis Lau / Lorraine Luk / Tim Tin / Sophia Wu Tel: (852) 2136 6952 / 2169 0467 / 3920 7654 / 3920 7645 Fax: (852) 3170 6606 Email: ech@iprogilvy.com
Source: EC Healthcare Sectors: BioTech, Healthcare & Pharm
Copyright ©2023 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 PHOENIX HARMONIA, A Very Large LPG/Ammonia Carrier Constructed by Namura Shipbuilding, Enters into Service Sep 29, 2023 17:11 JST
|  Stylish, Sporty, Spacious and All-Electric: Honda Prologue SUV Available Early Next Year with Anticipated EPA Range Rating of 300 Miles Sep 29, 2023 14:31 JST
|  MHI Thermal Systems Scores Highly Again with Air-Conditioners for Australia and New Zealand Markets Sep 29, 2023 11:51 JST
|  World's Best Honda Motorcycle Technician to be Determined at Inaugural Honda Global Motorcycle Technician Contest Sep 29, 2023 11:05 JST
|  Eisai Launches New "Innovation" Page on Corporate Website Sep 28, 2023 17:05 JST
|  Tokio Marine Nichido and Eisai Co-Develop Industry's First "Dementia Care Support Insurance" Sep 28, 2023 14:49 JST
|  NEC sets record for 800 Gbps long-distance transmission over an optical submarine cable system Sep 28, 2023 13:56 JST
|  JCB launches a special offer program in Hokkaido for inbound tourist to Japan Sep 28, 2023 13:00 JST
|  OREX Announces OREX Open RAN Service Lineup Sep 27, 2023 14:33 JST
|  Toyota and Woven by Toyota to Strengthen Ties Toward Accelerating Software Implementation Sep 27, 2023 13:11 JST
|  Fujitsu delivers O-RAN ALLIANCE-compliant 5G virtualized RAN solution for NTT DOCOMO's 5G commercial network services Sep 27, 2023 10:32 JST
|  DOCOMO to Transfer Ownership of 1,552 Telecommunication Towers to JTOWER to Promote Infrastructure Sharing Sep 27, 2023 10:03 JST
|  MHI and ZutaCore Join Forces in a Strategic Alliance, Paving the Way for a Zero-emission Data Industry Sep 27, 2023 09:00 JST
|  Overview of Honda Exhibits at the JAPAN MOBILITY SHOW 2023 Sep 26, 2023 17:25 JST
|  Fujitsu launches new technologies to protect conversational AI from hallucinations and adversarial attacks Sep 26, 2023 11:02 JST
|  Fujitsu and iSurgery launch bone health promotion project in Japan with Jikei University School of Medicine aiming for early detection of osteoporosis Sep 26, 2023 10:20 JST
|  Mitsubishi Motors to Showcase a Fulfilling Mobility Lifestyle that Awakens Drivers' Adventurous Spirit at the Japan Mobility Show 2023 Sep 25, 2023 17:50 JST
|  "LEQEMBI Intravenous Infusion" (Lecanemab) Approved for the Treatment of Alzheimer's Disease in Japan Sep 25, 2023 15:17 JST
| Value Research Center (VRC) at SSUNGA78: 'How Purpose, Value, and Impact will Drive a Sustainable Post-SDG Future' Sep 25, 2023 03:00 JST
|  TOYOTA GAZOO Racing returns to South American roads Sep 22, 2023 18:26 JST
|
More Latest Release >>
|